<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03470000_1</Organism_ID>
  <Organism>HIV-1</Organism>
  <Organism_Latin>Human immunodeficiency virus type 1</Organism_Latin>
  <UniProt_ID>P12497</UniProt_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>32</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CA</Alias>
      <Alias>Capsid protein p24</Alias>
  </Alias_List>
  <Molecule_Seq>
    <Protein_Seq>MGARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYNTIAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAADTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEEKAFSPEVIPMFSALSEGATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTTSTLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKARVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHIAKNCRAPRKKGCWKCGKEGHQMKDCTERQANFLREDLAFPQGKAREFSSEQTRANSPTRRELQVWGRDNNSLSEAGADRQGTVSFSFPQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKQKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYAGIKVRQLCKLLRGTKALTEVVPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMKGAHTNDVKQLTEAVQKIATESIVIWGKTPKFKLPIQKETWEAWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIIGAETFYVDGAANRETKLGKAGYVTDRGRQKVVPLTDTTNQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVSQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDGLVSAGIRKVLFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTVHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVIESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPVWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Virion</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>gag-pol</Gene_Name>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor</PDB_Title>
      <PDB_ID>4ID1</PDB_ID>
      <Resolution>1.87</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4ID1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01670001</ASD_Ligand>
      <PubMed_Title>Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.</PubMed_Title>
      <Author>Jurado, K.A., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2013)110:8690-8695</Journal>
      <PubMed_ID>23610442</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain A128T Mutant Complexed with Allosteric Inhibitor</PDB_Title>
      <PDB_ID>4JLH</PDB_ID>
      <Resolution>2.09</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4JLH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062031</ASD_Ligand>
      <PubMed_Title>The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.</PubMed_Title>
      <Author>Feng, L., et al.</Author>
      <Journal>J.Biol.Chem.(2013)288:15813-15820</Journal>
      <PubMed_ID>23615903</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A swapped dimer of the HIV-1 capsid C-terminal domain</PDB_Title>
      <PDB_ID>2ONT</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ONT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Domain-swapped dimerization of the HIV-1 capsid C-terminal domain</PubMed_Title>
      <Author>Ivanov D, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A.2007 Mar 13;104(11):4353-8. Epub  2007 Mar 5.</Journal>
      <PubMed_ID>17360528</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AHV</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AHV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470020</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor (2S)-tert-butoxy[6-(5-chloro-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenylpyridin-3-yl]ethanoic acid</PDB_Title>
      <PDB_ID>4O55</PDB_ID>
      <Resolution>2.24</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4O55</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470026</ASD_Ligand>
      <PubMed_Title>A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.</PubMed_Title>
      <Author>Sharma, A., et al.</Author>
      <Journal>Plos Pathog.(2014)10:e1004171-e1004171</Journal>
      <PubMed_ID>24874515</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (L211S) in complex with an inhibitor of particle assembly (CAI)</PDB_Title>
      <PDB_ID>3DS4</PDB_ID>
      <Resolution>1.12</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (E187A) in complex with an inhibitor of particle assembly (CAI)</PDB_Title>
      <PDB_ID>3DS1</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS1</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-ray Structure of Hexameric HIV-1 CA</PDB_Title>
      <PDB_ID>3H4E</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H4E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of the hexameric building block of the HIV capsid.</PubMed_Title>
      <Author>Pornillos O, et al.</Author>
      <Journal>Cell.2009 Jun 26;137(7):1282-92. Epub  2009 Jun 11.</Journal>
      <PubMed_ID>19523676</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (E187A)</PDB_Title>
      <PDB_ID>3DTJ</PDB_ID>
      <Resolution>4.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DTJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-ray Structure of Hexameric HIV-1 CA</PDB_Title>
      <PDB_ID>3GV2</PDB_ID>
      <Resolution>7.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GV2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of the hexameric building block of the HIV capsid.</PubMed_Title>
      <Author>Pornillos O, et al.</Author>
      <Journal>Cell.2009 Jun 26;137(7):1282-92. Epub  2009 Jun 11.</Journal>
      <PubMed_ID>19523676</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design</PDB_Title>
      <PDB_ID>3NFA</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NFA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01670008</ASD_Ligand>
      <PubMed_Title>Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</PubMed_Title>
      <Author>Rhodes, D.I., et al.</Author>
      <Journal>ANTIVIR.CHEM.CHEMOTHER.(2011)21:155-168</Journal>
      <PubMed_ID>21602613</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain A128T Mutant Complexed with Allosteric Inhibitor</PDB_Title>
      <PDB_ID>4GVM</PDB_ID>
      <Resolution>2.16</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GVM</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060053</ASD_Ligand>
      <PubMed_Title>The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.</PubMed_Title>
      <Author>Feng, L., et al.</Author>
      <Journal>J.Biol.Chem.(2013)288:15813-15820</Journal>
      <PubMed_ID>23615903</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of synthetic HIV-1 capsid C-terminal domain (CCA)</PDB_Title>
      <PDB_ID>3LRY</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LRY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Limitations of peptide retro-inverso isomerization in molecular mimicry, and why.</PubMed_Title>
      <Author>Li C, et al.</Author>
      <Journal>J Biol Chem.2010 Apr 9. [Epub ahead of print]</Journal>
      <PubMed_ID>20382735</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AHU</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AHU</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD06710009</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AHR</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AHR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470016</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (L211S)</PDB_Title>
      <PDB_ID>3DPH</PDB_ID>
      <Resolution>2.01</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DPH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AH9</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AH9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470015</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design</PDB_Title>
      <PDB_ID>3NF7</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NF7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470034</ASD_Ligand>
      <PubMed_Title>Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</PubMed_Title>
      <Author>Rhodes, D.I., et al.</Author>
      <Journal>ANTIVIR.CHEM.CHEMOTHER.(2011)21:155-168</Journal>
      <PubMed_ID>21602613</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design</PDB_Title>
      <PDB_ID>3NF6</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NF6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01670030</ASD_Ligand>
      <PubMed_Title>Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</PubMed_Title>
      <Author>Rhodes, D.I., et al.</Author>
      <Journal>ANTIVIR.CHEM.CHEMOTHER.(2011)21:155-168</Journal>
      <PubMed_ID>21602613</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (N183A) in complex with an inhibitor of particle assembly (CAI)</PDB_Title>
      <PDB_ID>3DS0</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-ray Structure of Hexameric HIV-1 CA</PDB_Title>
      <PDB_ID>3H47</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3H47</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>X-ray structures of the hexameric building block of the HIV capsid.</PubMed_Title>
      <Author>Pornillos O, et al.</Author>
      <Journal>Cell.2009 Jun 26;137(7):1282-92. Epub  2009 Jun 11.</Journal>
      <PubMed_ID>19523676</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A high-resolution NMR structure of the dimeric C-terminal domain of HIV-1 CA</PDB_Title>
      <PDB_ID>2KOD</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2KOD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural Convergence between Cryo-EM and NMR Reveals Intersubunit Interactions Critical for HIV-1 Capsid Function</PubMed_Title>
      <Author>Byeon I.-J.L., et al.</Author>
      <Journal>(2009) Cell(Cambridge,Mass.) 139: 780-790</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE HIV-1 CAPSID PROTEIN DIMERIZATION DOMAIN AT 2.6A RESOLUTION</PDB_Title>
      <PDB_ID>1A43</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A43</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.</PubMed_Title>
      <Author>Worthylake DK, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr.1999 Jan;55(Pt 1):85-92. Epub  1999 Jan 1.</Journal>
      <PubMed_ID>10089398</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AHT</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AHT</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470018</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (N183A)</PDB_Title>
      <PDB_ID>3DS5</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design</PDB_Title>
      <PDB_ID>3NF9</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NF9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470032</ASD_Ligand>
      <PubMed_Title>Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</PubMed_Title>
      <Author>Rhodes, D.I., et al.</Author>
      <Journal>ANTIVIR.CHEM.CHEMOTHER.(2011)21:155-168</Journal>
      <PubMed_ID>21602613</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (Y169A) in complex with an inhibitor of particle assembly (CAI)</PDB_Title>
      <PDB_ID>3DS3</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor (2S)-tert-butoxy[6-(5-chloro-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenylpyridin-3-yl]ethanoic acid</PDB_Title>
      <PDB_ID>4O5B</PDB_ID>
      <Resolution>2.37</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4O5B</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470026</ASD_Ligand>
      <PubMed_Title>A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.</PubMed_Title>
      <Author>Sharma, A., et al.</Author>
      <Journal>Plos Pathog.(2014)10:e1004171-e1004171</Journal>
      <PubMed_ID>24874515</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for a new mechanism of inhibition of HIV integrase identified by fragment screening and structure based design</PDB_Title>
      <PDB_ID>3NF8</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NF8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470033</ASD_Ligand>
      <PubMed_Title>Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design</PubMed_Title>
      <Author>Rhodes, D.I., et al.</Author>
      <Journal>ANTIVIR.CHEM.CHEMOTHER.(2011)21:155-168</Journal>
      <PubMed_ID>21602613</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 capsid C-terminal domain mutant (Y169A)</PDB_Title>
      <PDB_ID>3DS2</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DS2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein.</PubMed_Title>
      <Author>Bartonova V, et al.</Author>
      <Journal>J Biol Chem.2008 Nov 14;283(46):32024-33. Epub  2008 Sep 4.</Journal>
      <PubMed_ID>18772135</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Parallel screening of a low molecular weight compound library: do differences in methodology affect hit identification</PDB_Title>
      <PDB_ID>4AHS</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4AHS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470017</ASD_Ligand>
      <PubMed_Title>Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J.Biomol.Screen(2013)18:147</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor</PDB_Title>
      <PDB_ID>4GW6</PDB_ID>
      <Resolution>2.65</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GW6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060053</ASD_Ligand>
      <PubMed_Title>The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.</PubMed_Title>
      <Author>Feng, L., et al.</Author>
      <Journal>J.Biol.Chem.(2013)288:15813-15820</Journal>
      <PubMed_ID>23615903</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor (2S)-tert-butoxy[4-(4-chlorophenyl)-6-(3,4-dimethylphenyl)-2,5-dimethylpyridin-3-yl]ethanoic acid</PDB_Title>
      <PDB_ID>4O0J</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4O0J</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470025</ASD_Ligand>
      <PubMed_Title>A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.</PubMed_Title>
      <Author>Sharma, A., et al.</Author>
      <Journal>Plos Pathog.(2014)10:e1004171-e1004171</Journal>
      <PubMed_ID>24874515</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Yu X, et al. Biomacromolecules. 2009,10(2):390-399.</Site_Reference>
      <Site_Type>Oligomerization</Site_Type>
      <PubMed_ID>19199580</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01670001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01670008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01670030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03470034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05068001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05068002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD06710009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>